GAfPA Blog

The GAfPA Patient Advocacy Blog

Eventos Latino Americanos

La Alianza Global se está preparando para compartir temas centrales de acceso de los pacientes en dos importantes eventos de política de América Latina este año. Reunión G20 ARGENTINA El G20 es el principal foro internacional para la cooperación económica, financiera y política. Los lideres mundiales participan en esto. Es un espacio clave para el … Continued

Upcoming Latin America Events

The Global Alliance is gearing up to share central issues of patient access in two major Latin American policy events this year. G20 ARGENTINA Meeting The G20 is the main international forum for economic, financial and political cooperation. World leaders participate in it. It is a key space for debate, decision-making and coordination on policies … Continued

Revamped EudraVigilance System Could Improve Drug Safety Reporting

  Preventable drug safety issues caused nearly 200,000 deaths across the European Union in 2017.  Now the European Medicines Agency is working to address that statistic by improving its drug track-and-trace system, known as EudraVigilance.     The EudraVigilance system compiles data about side effects caused by drugs that are either in the marketplace or … Continued

Are Regulators Too Hasty in Approving Cancer Drugs?

The British Medical Journal ignited debate earlier last month when it announced that about half of cancer drugs approved by the European Medicines Agency don’t improve survival or quality of life.  The claim begs several complex question: How can regulators evaluate drugs both quickly and effectively?  And whose values should determine access to drugs for … Continued

“Fast Facts” on Pharmacovigilance Tackles Drug Safety Issues

Drug safety issues have caused more than 200,000 patient deaths in the EU. And one in three U.S. drugs may have safety issues, explains a new “Fast Facts” from the Global Alliance for Patient Access.   The paper explores how countries track and trace prescription drug side effects – and why advanced medicine demands a stronger … Continued

BLOG: GAfPA Examines How Improving Drug Donations Can Boost Patient Access

Reposted from the Institute for Patient Access   International prescription drug donation programs make a difference, explains a new white paper from the Global Alliance for Patient Access.  But they could work even better. In “The Role of Drug Donations in Expanding Access to Medicines,” author Neeraj Mistry, MD, MPH, explains that, “Millions of low-income … Continued

VÍDEO: Entender El Cambio O Switch No Médico

Los pacientes con condiciones médicas crónicas o graves a veces deben trabajar con los médicos durante meses para identificar un medicamento que sea eficaz para ellos. Pero como lo explica este video, los pacientes pueden descubrir que este proceso de prueba y error fue en vano. A través del cambio o switch no médico, las … Continued

Munich 2017

The Global Alliance for Patient Access (GAfPA) and the European Federation of Crohn’s and Colitis Associations (EFCCA) came together to hold a Biologics and Biosimilars Patient Access and Advocacy Workshop in Munich, Germany on May 4-5, 2017. The 17 attendees from 13 different countries represented specialities from across rheumatology, gastroenterology and neurology, including several members … Continued